
Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc. (VTYX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · VTYX · as of Jun 8, 2026
Key Statistics
Explore Ventyx Biosciences, Inc. Data
vtyx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 30.8%
The VTYX analyst consensus is Hold, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $14.00, representing +0.00% upside from the current price of $14.00.
Competitors & Peers
vtyx competitorsStock Performance
Full HistoryAbout Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc. a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidat…
what is ventyx biosciences, inc. · vtyx stock overview · ventyx biosciences, inc. company profile · who is ventyx biosciences, inc. ceo · vtyx NASDAQ · ventyx biosciences, inc. headquarters · ventyx biosciences, inc. business segments
About Stock Overview & Key Data
Ventyx Biosciences, Inc. (VTYX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 21, 2021. As of the latest trading session, VTYX stock price is $14.00, with a market capitalization of $1.0B. The stock has returned +1574.44% over the past 12 months and +66.67% year-to-date.
According to 13 Wall Street analysts, the consensus rating for Ventyx Biosciences, Inc. stock is Hold, with an average 12-month price target of $14.00. In fiscal year 2024, Ventyx Biosciences, Inc. reported revenue of — and net income of -$135.1M. For detailed data — including Ventyx Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ventyx Biosciences, Inc. (VTYX) stock price is $14.00. The stock is traded on NASDAQ under the ticker symbol VTYX. The 52-week range is $0.78 – $25.00.